Apolipoprotein e gene polymorphism in a Chinese population with vascular dementia: A meta-analysis

Dementia and Geriatric Cognitive Disorders

Volumn 33, Issue 2-3, 2012, Pages 96-103

  Liu, Bo ^a   Shen, Yuefei ^a   Cen, Luan ^a   Tang, Yulan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Chinese population; Dementia; Gene polymorphism; Meta analysis; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ALLELE; APOLIPOPROTEIN E GENE; CHINESE; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MULTIINFARCT DEMENTIA; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

APOLIPOPROTEINS E; CHINA; CONFIDENCE INTERVALS; DEMENTIA, VASCULAR; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; ODDS RATIO; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS;

EID: 84858305541     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000337025     Document Type: Review

References (55)

1. Takeda M, Martinez R, Kudo T, Tanaka T, Okochi M, Tagami S, Morihara T, Hashimoto R, Cacabelos R: Apolipoprotein E and central nervous system disorders: Reviews of clinical findings. Psychiatry Clin Neurosci 2010; 64: 592-607.
2. Hill J, Fillit H, Shah SN, del Valle MC, Futterman R: Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population. J Alzheimers Dis 2005; 8: 43-50.
3. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P: Alzheimer's disease and vascular dementia in developing countries: Prevalence, management, and risk factors. Lancet Neurol 2008; 7: 812-826.
4. Zhang ZX, Zahner GE, Roman GC, Liu J, Hong Z, Qu QM, Liu XH, Zhang XJ, Zhou B, Wu CB, Tang MN, Hong X, Li H: Dementia subtypes in China: Prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005; 62: 447-453.
5. Frank A, Diez-Tejedor E, Bullido MJ, Valdivieso F, Barreiro P: APOE genotype in cerebrovascular disease and vascular dementia. J Neurol Sci 2002; 203-204: 173-176.
6. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630.
7. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D: Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke 1999; 30: 1548-1553.
8. Folin M, Baiguera S, Conconi MT, Di Liddo R, DeCarlo E, Parnigotto PP, Nussdorfer GG: Apolipoprotein E as vascular risk factor in neurodegenerative dementia. Int J Mol Med 2004; 14: 609-613.
9. Bales KR: Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology 2010; 59: 295-302.
10. Mahley RW, Weisgraber KH, Huang Y: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006; 103: 5644-5651.
11. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO: APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol 2008; 8: 9.
12. Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, Arrighi HM: Apolipoprotein E epsilon4 prevalence in Alzheimer's disease patients varies across global populations: A systematic literature review and meta-analysis. Dement Geriatr Cogn Disord 2011; 31: 20-30.
13. Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA: Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009; 361: 245-254.
14. Kim J, Basak JM, Holtzman DM: The role of apolipoprotein E in Alzheimer's disease. Neuron 2009; 63: 287-303.
15. Kwon OD, Khaleeq A, Chan W, Pavlik VN, Doody RS: Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample. Dement Geriatr Cogn Disord 2010; 30: 486-491.
16. Frisoni G, Geroldi C, Bianchetti A, Trabucchi M, Govoni S, Franceschini G, Calabresi L: Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease. Stroke 1994; 25: 1703-1704.
17. Baum L, Lam LC, Kwok T, Lee J, Chiu HF, Mok VC, Wong A, Chen X, Cheung WS, Pang C P, Ma SL, Tang NL, Wong KS, Ng HK: Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dement Geriatr Cogn Disord 2006; 22: 301-305.
18. Paradowski B, Dobosz T, Sasiadek M, Szczepaniak M: Apolipoprotein E and tau protein in vascular dementia (in Polish). Pol Merkur Lekarski 2003; 15: 69-71.
19. Engelborghs S, Dermaut B, Goeman J, Saerens J, Marien P, Pickut BA, VandenBroeck M, Serneels S, Cruts M, Van Broeckhoven C, DeDeyn PP: Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 2003; 74: 1148-1151.
20. Chapco W: An exact test of the Hardy-Weinberg law. Biometrics 1976; 32: 183-189.
21. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
22. Bowden J, Tierney JF, Copas AJ, Burdett S: Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011; 11: 41.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
24. Ioannidis JP, Patsopoulos NA, Evangelou E: Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007; 335: 914-916.
25. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
26. Saltelli A: Sensitivity analysis for importance assessment. Risk Anal 2002; 22: 579-590.
27. Zhang XQ, Xiao JS, Huang CY: Relationship between apolipoprotein E gene polymorphism and vascular dementia. Chin J Med Genet 1997; 14: 31-34.
28. Zhu L, Cui TP, Tong ET: Association between genetic polymorphism of apolipoprotein E and serum lipids in patients with vascular dementia. Acta Univ Med Tongji 2000; 29: 3.
29. Zhang J, Jia JP, Zhang XQ, Dong HQ, Zhou WD, Yang JF, Dong XM: An analysis of apolipoprotein E polymorphism in patients with vascular dementia. Chin J Geriatr Heart Brain Vessel Dis 2001; 3: 4.
30. Zhang JG, Yang JG, Lin ZX, He L, Feng GY, Ma XY, Wang CF, Lu PF, Song SB, Dong XZ, St Clair D, Breen G: Apolipoprotein E epsilon4 allele is a risk factor for late-onset Alzheimer's disease and vascular dementia in Han Chinese. Int J Geriatr Psychiatry 2001; 16: 438-439.
31. Huang HM, Kuo YM, Ou HC, Lin CC, Chuo LJ: Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population. J Neural Transm 2002; 109: 1415-1421.
32. Lin XJ, Hu CL, Xie YL, Zhang X, Liu XP, Ran G: The relation between polymorphism of apolipoprotein E gene and vascular dementia. Chin J Neuroimmunol Neurol 2002; 9: 4.
33. Xu LG, Li ZH: The relation between polymorphism of apolipoprotein E gene and vascular dementia. J Clin Neurol 2002; 15: 2.
34. Lai CL, Tai CT, Lin SR, Lin RT, Yang YH, Liu CK: Apolipoprotein E in Taiwan Chinese patients with dementia. Dement Geriatr Cogn Disord 2003; 16: 208-211.
35. Lu HY, Tian GL, Wang JH, Ning XJ: The relation between polymorphism of apolipoprotein E gene and vascular dementia. Mod J Neurol Neurosurg 2003; 3: 4.
36. Su J, Tan L, Chang GF: An analysis of apolipoprotein E polymorphism in patients with vascular dementia. Chin J Nerv Ment Dis 2003; 29: 4.
37. Wang QF, Zhao GP: The relation between polymorphism of apolipoprotein E gene and vascular dementia. J Henan Univ (Med Sci) 2003; 22: 1.
38. Lin HF, Lai CL, Tai CT, Lin RT, Liu CK: Apolipoprotein E polymorphism in ischemic cerebrovascular diseases and vascular dementia patients in Taiwan. Neuroepidemiology 2004; 23: 129-134.
39. Zhang Y, Liu ZF, Du YF, Liu ZH, Li JF, Xie ZJ, Xing T: An analysis of apolipoprotein E polymorphism in patients with vascular dementia or Alzheimer. Shandong Med J 2004; 44: 2.
40. Feng YQ, Wang JH, Guo X, Sun ZY, Liu GF, Chen JH, Gao JS, Li ZL, Qi YC, Ha ZY: The relation of polymorphism of apolipoprotein E gene and serum lipid in patients with vascular dementia. Chin J Neuroimmunol Neurol 2005; 12: 2.
41. Yang JY, Yu FC, Wang Y, Wu L, Wang YM, Duan Y, Yang Y, Chen Y, Zhu N, Ye Y, Zhang Y, Li C, Wu X: Study of the polymorphisms of APOE gene in Alzheimer disease and vascular dementia. Nerv Dis Mental Health 2008; 8: 3.
42. Li GR, Zhao MX, Zuo L, Liu F: The relation between polymorphism of apolipoprotein E 4 gene and vascular dementia. Contemp Med 2009; 15: 2.
43. Jiang WY, Lv ZP, Qin L, Hu CY, Pang GF, Yang Z, Wei Y, Lv Y: Correlation between apolipoprotein E gene polymorphisms and Alzheimer's disease and vascular dementia. J Clin Neurol 2010; 23:6.
44. Roman GC: Vascular dementia: Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003; 51:S296-S304.
45. Hixson JE: Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 1991; 11: 1237-1244.
46. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K: Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 1999; 9: 243-245.
47. McCarron MO, Delong D, Alberts MJ: APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis. Neurology 1999; 53: 1308-1311.
48. Gdovinova Z, Habalova V, Novosadova Z: Polymorphism of apolipoprotein E in relation with Alzheimer and vascular dementia. Cell Mol Neurobiol 2006; 26: 1219-1224.
49. McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP: Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia. Neurosci Lett 2010; 483: 62-66.
50. Davidson Y, Gibbons L, Purandare N, Byrne J, Hardicre J, Wren J, Payton A, Pendleton N, Horan M, Burns A, Mann DM: Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dement Geriatr Cogn Disord 2006; 22: 15-19.
51. Kalman J, Juhasz A, Csaszar A, Kanka A, Rimanoczy A, Janka Z, Rasko I: Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population. Acta Neurol Scand 1998; 98: 166-168.
52. Kim KW, Youn JC, Han MK, Paik NJ, Lee TJ, Park JH, Lee SB, Choo IH, Lee DY, Jhoo JH, Woo JI: Lack of association between apolipoprotein E polymorphism and vascular dementia in Koreans. J Geriatr Psychiatry Neurol 2008; 21: 12-171.
53. Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nikkari T: The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996; 93: 352-354.
54. Schmidt H, Schmidt R, Fazekas F, Semmler J, Kapeller P, Reinhart B, Kostner GM: Apolipoprotein E e4 allele in the normal elderly: Neuropsychologic and brain MRI correlates. Clin Genet 1996; 50: 293-299.
55. Leoni V: The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease. Clin Chem Lab Med 2011; 49: 375-383.